首页> 美国卫生研究院文献>American Journal of Translational Research >Emerging role of C5a/C5aR IL-17A axis in cGVHD
【2h】

Emerging role of C5a/C5aR IL-17A axis in cGVHD

机译:C5a / C5aR IL-17A轴在cGVHD中的新兴作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic graft-versus-host disease (cGVHD) manifests with features characteristic of autoimmune disease with organs attacked by pathogenic Th17 cells. However, the mechanism of Th17 cells generation in the setting of cGVHD is still unclear. Here we defined C5a/C5aR-IL-17Aaxis as a novel signaling that required in the pathologies of cGVHD. We firstly found a positive link between complement activation and the Th17 cells in patients with cGVHD. C5a, a critical component of complements, promoted the generation of Th17 cells in vitro and inhibition of the receptor for C5a (C5aR) reduced the Th17-bias response. Of note, C5aR blockade by PMX53 could suppress the generation of IL-17A-expressing Th17 cells and retard the onset and progression of cGVHD in vivo. Overall, our results provide new mechanistic insights that activation of C5a-C5aR signaling was required for IL-17A-induced immune responses in cGVHD and define novel molecular targets for developing effective therapeutics for cGVHD.
机译:慢性移植物抗宿主病(cGVHD)表现为自身免疫性疾病的特征,其病原体为Th17细胞攻击的器官。然而,在cGVHD环境中Th17细胞生成的机制仍不清楚。在这里,我们将C5a / C5aR-IL-17Aaxis定义为cGVHD病理所必需的新型信号传导。我们首先发现cGVHD患者补体激活与Th17细胞之间存在正相关。 C5a是补体的重要组成部分,在体外可促进Th17细胞的生成,抑制C5a受体(C5aR)可降低Th17偏倚反应。值得注意的是,PMX53对C5aR的阻断作用可以抑制表达IL-17A的Th17细胞的生成,并抑制体内cGVHD的发生和发展。总体而言,我们的结果提供了新的机制见解,即cGVHD中IL-17A诱导的免疫反应需要激活C5a-C5aR信号,并为开发有效的cGVHD治疗方法确定了新的分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号